Iihara Koji, Murao Kenichi, Yamada Naoaki, Takahashi Jun C, Nakajima Norio, Satow Tetsu, Hishikawa Tomohito, Nagata Izumi, Miyamoto Susumu
Department of Neurosurgery, National Cardiovascular Center, Suita, Japan.
Neurosurgery. 2008 Nov;63(5):832-42; discussion 842-4. doi: 10.1227/01.NEU.0000313625.15571.1B.
This study examined the growth potential and response to multimodality treatment of partially thrombosed large or giant aneurysms in the posterior circulation.
The 17 aneurysms arose from nonbranching sites of the vertebral artery (VA) in 6 patients and from branching sites in 11 patients (the VA-posteroinferior cerebellar artery [PICA], 3 cases; basilar artery [BA] fenestration, 1 case; BA-superior cerebellar artery [SCA], 5 cases; and BA tip, 2 cases).
Endovascular trapping was performed in 5 VA aneurysms at nonbranching sites, 2 VA-PICA cases with or without revascularization of the PICA, and 1 BA fenestration case. Endosaccular embolization was performed in 2 BA-SCA aneurysms as the sole treatment or after superficial temporal artery-SCA bypass for a broad-necked lesion. Surgical proximal occlusion (PO) with or without revascularization of the PICA was performed in 2 VA cases. Endovascular treatment failed to prevent growth in 1 VA-PICA case and the broad-necked BA-SCA case. Simple flow alteration by PO of 3 BA aneurysms, with gadolinium enhancement on T1-weighted images, did not prevent growth. Maximum flow reduction by various combinations of bypass (superficial temporal artery-posterior cerebral artery or superficial temporal artery-SCA) and BA PO, aimed at reducing hemodynamic stress on the neck, was tailored to 5 cases, including those refractory to PO; it achieved marked shrinkage in 2 cases and stabilization of the aneurysms in 3 cases. The aneurysms harboring neither gadolinium enhancement nor hyperintensity on fluid-attenuated inversion recovery images showed significantly lower growth potential before treatment and a lesser degree of shrinkage after tailored treatment than the remaining cases (P = 0.03 and P = 0.01, respectively). Overall, marked shrinkage was achieved in 27%, moderate shrinkage in 20%, stabilization in 47%, enlargement in 7%, and favorable outcome in 71%. Maximum flow reduction strategy for BA aneurysms tended to show higher shrinking efficacy than endovascular trapping for VA and BA aneurysms (P = 0.08).
For aneurysms at nonbranching sites, endovascular trapping may be effective, although its shrinking efficacy may be moderate. For the most formidable BA aneurysms at branching sites, maximum flow reduction may cause marked shrinkage, even of aggressive lesions.
本研究探讨后循环部分血栓形成的大型或巨大动脉瘤的生长潜力及对多模式治疗的反应。
17例动脉瘤中,6例起源于椎动脉(VA)非分支部位,11例起源于分支部位(椎动脉-小脑后下动脉[PICA],3例;基底动脉[BA]开窗,1例;BA-小脑上动脉[SCA],5例;BA尖端,2例)。
5例VA非分支部位动脉瘤、2例有或无PICA血运重建的VA-PICA动脉瘤及1例BA开窗动脉瘤行血管内包裹术。2例BA-SCA动脉瘤行囊内栓塞作为唯一治疗方法,或在颞浅动脉-SCA搭桥术后用于治疗宽颈病变。2例VA动脉瘤行手术近端闭塞(PO),有或无PICA血运重建。1例VA-PICA动脉瘤和1例宽颈BA-SCA动脉瘤血管内治疗未能阻止其生长。3例BA动脉瘤通过PO单纯改变血流,T1加权像上有钆增强,未能阻止其生长。针对5例(包括对PO难治的病例)采用旁路(颞浅动脉-大脑后动脉或颞浅动脉-SCA)和BA PO的各种组合以最大程度减少瘤颈血流动力学压力,其中2例显著缩小,3例动脉瘤稳定。在液体衰减反转恢复图像上既无钆增强也无高信号的动脉瘤,治疗前生长潜力显著较低,经针对性治疗后缩小程度小于其余病例(分别为P = 0.03和P = 0.01)。总体而言,27%显著缩小,20%中度缩小,47%稳定,7%增大,71%预后良好。BA动脉瘤的最大血流减少策略收缩疗效往往高于VA和BA动脉瘤的血管内包裹术(P = 0.08)。
对于非分支部位的动脉瘤,血管内包裹术可能有效,但其收缩疗效可能中等。对于分支部位最棘手的BA动脉瘤,最大程度减少血流可能导致显著缩小,即使是侵袭性病变。